Jan Willem Alffenaar

Vision Statement

To influence patient-centred therapeutic drug monitoring and clinical toxicology at a global level, the IATDMCT should embrace international collaborative multidisciplinary research, thereby delivering high impact research. By developing an interactive regional training, education and professional development program, focused on early career researchers and clinicians, the IATDMCT will be positioned to attract creative and inspiring leaders of the future to deliver its promise to patients and their families to improve their health and well-being.


  • Since 2019 (professor of Clinical Pharmacy)
    • University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia
    • Westmead Hospital, Western Sydney Local Health District, Sydney, Australia
  • 2013-2018 (hospital pharmacist – associate professor)
    • University Medical Center Groningen, Groningen, the Netherlands
  • 2009-2013 (hospital pharmacist – assistant professor)
    • University Medical Center Groningen, Groningen, the Netherlands
  • 2005-2008 (hospital pharmacist – in residency)
    • University Medical Center Groningen, Groningen, the Netherlands
  • 2002-2004 (pharmacist)
    • University Medical Center Groningen, Groningen, the Netherlands
  • 1995-2000 University of Groningen, MSc of Pharmacy
  • 2000-2002 University of Groningen, PharmD
  • 2005-2008 University Medical Center Groningen, residency in Hospital Pharmacy
  • 2006-2009 University of Groningen, PhD in Medicine
  • 2009-2011 University Medical Center Groningen, specialty training in Clinical Pharmacology

Memberships: IATDMCT, NVZA (Dutch Society of Hospital Pharmacists), NvKFB (Dutch association for Clinical Pharmacology and biopharmaceutics), KNMP (Royal Dutch Society of Pharmacy), The International Union Against Tuberculosis and Lung Disease, ESCMID (European Society of Microbiology and Infectious Diseases, ASID (Australasian Society of Infectious Diseases, ISAP (International Society of Anti-Infective Pharmacology), ASM (American Society for Microbiology)

Committees: member of Human Ethics Research Committee, member of Scientific Advisory Committee, member of Clinical Trials Advisory Committee, member of Drug Committee WSLHD, Global Tuberculosis Network – Clinical Pharmacology Committee (chair)

IATDMCT activities: editorial board member TDM, past vice chair/past chair Anti-infective committee, past vice chair/past chair/current vice chair of Alternative Sampling Committee, Local Scientific advisory Committee IATDMCT Conference 2015, recipient of Victor Armstrong Young Investigator award 2015

Professional appointments: editorial board member Journal of Mass Spectrometry & Advances in the Clinical Lab, associate editor International Journal of Tuberculosis and Lung Disease, Expert advisor on Clinical Pharmacology of TB drugs WHO-ERS-ECDC Concilium

Number of publications: 301 publications in peer reviewed journals

Invited speaker: > 80 invited lectures on national and international conferences